Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | XIAP | P98170 | 2/20 | 0.32 |
| ▸ | BIRC3 | Q13489 | 2/20 | 0.32 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12820561 | 0.92 | ADRB3 (0.31) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL12819722 | 0.91 | XIAP (0.33) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL12819719 | 0.91 | ADRB3 (0.31) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL12820553 | 0.89 | TERF2 (0.32) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL12820551 | 0.88 | ADRB3 (0.31) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL12820547 | 0.88 | ADRB3 (0.40) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL12820552 | 0.86 | ADRB3 (0.30) | ADRB3ADRA2BADRA2C | |
| SCHEMBL8237929 | 0.86 | DPP4 (0.34) | — | |
| SCHEMBL12820550 | 0.85 | CTSB (0.40) | CCR2ADRB3ADRA2BADRA2CXIAP | |
| SCHEMBL11976374 | 0.82 | ADRB3 (0.36) | ADRB3ADRA2BADRA2CXIAPBIRC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011034518-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2011-03-24 | — | — | WO | disclosed |